ENDPOINTS

Jazz to buy Chimerix for $935M to get brain tumor drug five months ahead of PDUFA

Jazz Pharmaceuticals will buy North Carolina biotech Chimerix for $935 million in cash, the companies said Wednesday morning. Through the deal, Jazz gets access to a potential first-ever treatment for a ...

Mar 5, 2025 - 13:40
 0
Jazz to buy Chimerix for $935M to get brain tumor drug five months ahead of PDUFA
Jazz Pharmaceuticals will buy North Carolina biotech Chimerix for $935 million in cash, the companies said Wednesday morning. Through the deal, Jazz gets access to a potential first-ever treatment for a ...
Read More

Tags:

Previous Article

Use your research to beat health inequities: four strategies from experts

Next Article

NASA’s SpaceX Crew-10 to Explore Deep Space Exercise, Health

Related Posts

Supernus’ stock sinks after placebo effect derails mid-stage depression study

Supernus’ stock sinks after placebo effect derails mid-...

Feb 19, 2025  0

Trump’s HHS defends drug price negotiations in Novartis suit

Trump’s HHS defends drug price negotiations in Novartis...

Feb 20, 2025  0

Acelyrin rejects buyout offer from Tang’s Concentra, sticks to Alumis merger

Acelyrin rejects buyout offer from Tang’s Concentra, st...

Mar 4, 2025  0